These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17251983)

  • 1. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
    Cohen JC; Mrazek M; Hawkins L
    Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceuticals--strategic considerations in health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S100-11. PubMed ID: 17595837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].
    Maïga D; Maïga S; Maïga MD
    Med Trop (Mars); 2010 Apr; 70(2):184-8. PubMed ID: 20486360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to essential drugs in Guyana: a public health challenge.
    Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Health Plann Manage; 2010; 25(1):2-16. PubMed ID: 18536003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs and development: the global impact of drug use and trafficking on social and economic development.
    Singer M
    Int J Drug Policy; 2008 Dec; 19(6):467-78. PubMed ID: 19038724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings.
    Russo G; McPake B
    Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
    Morgan S; McMahon M; Greyson D
    Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health and economic consequences of counterfeit drugs.
    Seiter A
    Clin Pharmacol Ther; 2009 Jun; 85(6):576-8. PubMed ID: 19451909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fake malaria drugs].
    Bygbjerg IC
    Ugeskr Laeger; 2009 Mar; 171(10):815-7. PubMed ID: 19265610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 15. Tackling Pharma corruption in Ukraine.
    Colborne M
    CMAJ; 2017 Aug; 189(34):E1101-E1102. PubMed ID: 28847787
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Realities of paediatric pharmacotherapy in the developing world.
    Hoppu K; Sri Ranganathan S; Dodoo AN
    Arch Dis Child; 2011 Aug; 96(8):764-8. PubMed ID: 21441240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A perspective on Australia's National Medicines Policy.
    Tett SE
    Can J Clin Pharmacol; 2004; 11(1):e28-38. PubMed ID: 15226524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication safety issue brief. Counterfeit drug prevention and identification.
    ; ;
    Hosp Health Netw; 2005 Aug; 79(8):29-30. PubMed ID: 16247941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.